Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen

Arjen Gebraad, Roope Ohlsbom, Juho J. Miettinen, Promise Emeh, Toni-Karri Pakarinen, Mikko Manninen, Antti Eskelinen, Kirsi Kuismanen, Ana Slipicevic, Fredrik Lehmann, Nina N. Nupponen, Caroline A. Heckman, Susanna Miettinen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number1574
JournalCells
Volume11
Issue number9
Number of pages22
ISSN2073-4409
DOIs
Publication statusPublished - May 2022
MoE publication typeA1 Journal article-refereed

Fields of Science

  • melflufen
  • melphalan flufenamide
  • peptide-drug conjugate
  • mesenchymal stem
  • stromal cells
  • multiple myeloma
  • bone marrow
  • drug sensitivity
  • osteogenesis
  • adipogenesis
  • angiogenesis
  • FLUOROPHENYLALANINE ETHYL-ESTER
  • ALKYLATING PRODRUG J1
  • ANGIOGENESIS IN-VITRO
  • STEM-CELLS
  • OSTEOGENIC DIFFERENTIATION
  • ANTITUMOR EFFICACY
  • ENDOTHELIAL-CELLS
  • AMINOPEPTIDASE-N
  • STROMAL CELLS
  • EX-VIVO
  • 1182 Biochemistry, cell and molecular biology

Cite this